{
”subject”: ”Ribociclib API Supply Partnership for Ali Raif’s Generic Pipeline”,
”content”: ”
As Ali Raif continues to expand its pharmaceutical portfolio and R&D-driven pipeline, the upcoming patent expiry of Ribociclib (Kisqali) by ~2029 offers a strategic window for generic preparation. With your company’s focus on cardiology and oncology-adjacent therapeutic areas, we believe our API supply solution can support your future product launch and registration goals.
Unibest Industrial Co., Ltd. supplies high-quality Ribociclib API under project code UBX11. Our product is GMP-compliant and available with DMF/CEP/ASMF documentation to facilitate your regulatory filings. We have a robust manufacturing process with stringent control over genotoxic impurities, including nitrosamines, ensuring compliance with international pharmacopoeia standards.
Our commitment to stable commercial supply, competitive pricing, and timely delivery makes us a reliable partner for your sourcing needs. We tailor our support to help you progress from early development through to commercialization seamlessly.
We would be glad to provide a detailed specification sheet, reference samples, or schedule a technical call to discuss how our Ribociclib API aligns with your needs. Please feel free to reach out.
For more product information, please visit: Chemical Compositions
For biological ingredients, please visit: Biological Ingredients
”
}
